Philip H. Coelho - 04 May 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Philip H. Coelho
Issuer symbol
CPRX
Transactions as of
04 May 2023
Net transactions value
+$39,500
Form type
4
Filing time
05 May 2023, 17:00:24 UTC
Previous filing
17 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $39,500 +50,000 +32% $0.7900* 204,887 04 May 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase Common Stock Award $0 -50,000 -16% $0.000000 260,500 04 May 2023 Common Stock 50,000 $0.7900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vested in two annual tranches beginning on June 15, 2017.